Human Growth Peptides Bodybuilding Hormone Selank Safe Pass
Informations de base :
| Nom |
Selank |
| Alias |
Selanc |
| Cas |
129954-34-3 |
| M. F |
C33H57N11O9 |
| Masse moléculaire |
751.9 |
| Pureté |
99.00% |
| Apparence |
Poudre lyophilisée blanche |
| Séquence |
Thr-Lys-PRO-Arg-PRO-Gly-PRO |
| Taille de l'unité |
5mg per vial |
| Delivery time |
Dans 18 hours upon receipt of payment |
| Livraison |
SMU, DHL, TNT, Fedex, UPS etc |
| Espace de rangement |
Peptides lyophilisés bien que stables à température ambiante pendant 3 mois, doit être stocké desséché en dessous de -18° C. Une fois reconstitué, le peptide doit être conservé à 4° C entre 2-21 jours et pour une utilisation future en dessous de -18° C. |
| Usage |
inhibit enzymes involved in the degradation of enkephalins and other endogenous regulatory peptides |
La description
Selank is a nootropic, anxiolytic peptide based drug developed by the Institute of Molecular Genetics of the Russian Academy of Sciences. Selank is a heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. It is a synthetic analogue of a human tetrapeptide tuftsin.
Selank, as well as a related peptide drug, semax, have been found to inhibit enzymes involved in the degradation of enkephalins and other endogenous regulatory peptides, and this action may be involved in their effects.
Influence
The influence of a new heptapeptide Selank on microcirculation in anesthetized white rats was investigated. Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro) is a new synthetic anxiolytic which exerts obvious antiulcerogenic action and promotes healing of experimental ulcers.
Action of the peptide on gastric blood flow in the stomach by using the method ofhydrogenic clearance and Selank action on mesenteric lymphatic contractility by microscopical observation in situ, were studied. Selank fail to influence basal gastric blood flow but it can normalize blood flow reduced by indomethacin.
Directeur commercial